Dare Bioscience Inc (NAS:DARE)
$ 3.2711 -0.1 (-2.98%) Market Cap: 27.96 Mil Enterprise Value: 13.07 Mil PE Ratio: 0.21 PB Ratio: 10.45 GF Score: 34/100

Dare Bioscience Inc at H C Wainwright BioConnect Conference (Virtual) Transcript

Jan 11, 2021 / 11:00AM GMT
Release Date Price: $15.96 (-3.62%)
Douglas Dylan Tsao
H.C. Wainwright & Co, LLC, Research Division - MD & Senior Healthcare Analyst

Good morning, everybody. This is Doug Tsao from -- senior analyst at H.C. Wainwright. Thank you, everybody, for joining us for the BioConnect Conference. We are thrilled to have Sabrina Johnson, the CEO of Daré Biosciences (sic) [Daré Biosciences] with us today to talk about the company. So with that, why don't we jump right in because we don't have a ton of time. So Sabrina, you're a company -- or Daré is a company that came to the public markets through a reverse merger. And so I think there is still many investors who aren't familiar with the company's story. So maybe as a starting point, it's always good -- helpful to sort of orient people and provide just an introduction of what Daré is all about and...

Sabrina Martucci Johnson;Bioscience
DarÃ;Inc. - President, CEO, Secretary & Director

© -

Great. Great. Happy to. So thank you, first of all, for the opportunity and for this format. It's a great format. So in terms of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot